Abstract:Lung adenosquamous carcinoma (ASC) is a rare heterogeneous tumor containing two distinct components of adenocarcinoma (ADC) and squamous cell carcinoma (SQCC). The limited biopsy sampling of the primary tumor might have overlooked either the ADC component or the SQCC component, resulting in a misdiagnosis of pure histology. Genotyping for driver mutations is now routinely performed in clinical settings to identify actionable oncogenic mutations and gene arrangements. Additionally, somatic mutations can potentially serve as a marker of clonal relationships. We report a rare case of ASC lung cancer, in which metastases were identified as ADC, while the primary was initially diagnosed as SQCC based on a fibrobronchoscope brush biopsy. The primary and metastatic tumors shared ALK rearrangement and other mutations support they were derived from a single clone origin. Our hypothesis is that the primary tumor contained a minor component of ADC that was not present in the histologic sections of lung biopsy. After sequential ALK -tyrosine kinase inhibitor (TKI) targeted therapy, both the patient's primary lung tumor and the site of metastatic subcutaneous nodules decreased in size, with the metastatic sites demonstrating more noticeable shrinkage. However, after 11 months of targeted therapy, the patient was found to be resistant to ALK -TKIs. Subsequently, the patient's respiratory status deteriorated rapidly, and a cycle of immunotherapy and chemotherapy did not show efficacy. To the best of our knowledge, this is a very rare case of lung ASC, disseminated metastasizing, with distinct morphology between the primary and metastases. Different therapeutic effects of ALK -TKIs were observed in two different morphological sites, with the metastatic cutaneous lesions shrinking more significantly than the primary lung lesions, though they both harbor the same EML4 - ALK rearrangement. This case may provide diagnostic and therapeutic insights into lung ASC.

A rare case report of a primary lung cancer comprising adenocarcinoma and atypical carcinoid tumor, with the carcinoid component harboring EML4-ALK rearrangement

Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement

A Case Of Primary Pulmonary Atypical Carcinoid With Eml4-Alk Rearrangement

Primary lung adenocarcinoma with breast metastasis harboring the EML4‐ALK fusion: A case report

ALK -rearrangement neuroendocrine carcinoma of the lung: a comprehensive study of a rare case series and review of literature.

Lung Adenocarcinoma with Concurrent ALK and ROS1 Rearrangement: A Case Report and Review of the Literatures

Case Report: Response to ALK-TKIs in a metastatic lung cancer patient with morphological heterogeneity and consistent molecular features

Different Histopathology but the Same Clonality: ALK Rearrangement in a Patient with Metastatic Non-Small-cell Lung Cancer.

A Case of Small Cell Lung Carcinoma Harboring an EML4–ALK Fusion with Partial Response to Crizotinib

Case report: Concomitant EGFR mutation and ALK rearrangement in non-small cell lung cancer

[Anaplastic Lymphoma Kinase-Positive Adenocarcinoma of Lung: a Cytopathologic Analysis].

Clinical Characteristics and Outcomes of Patients with Primary Lung Adenocarcinoma Harboring Alk Rearrangements Detected by Fish, Ihc, and Rt-Pcr

[A case report: an EML4-ALK positive lung adenocarcinoma diagnosed with lymphoma previously]

Ott_a_335736 5385..5389

Case Report: Patient With Lung Adenocarcinoma With ALK-HLA-DRB1 Rearrangement Shows Impressive Progression-Free Survival After Sequential Crizotinib and Ceritinib Treatment

Lung Cancer with Concurrent EGFR Mutation and ROS1 Rearrangement: a Case Report and Review of the Literature

A Case of Simultaneously Diagnosed Lung Adenocarcinoma and Endobronchial Inflammatory Myofibroblastic Tumor with Two Distinct Types of ALK Translocation

Sarcoidosis Mimicking Metastases in an Echinoderm Microtubule-Associated Protein-Like 4 Anaplastic Lymphoma Kinase Positive Non-Small-lung Cancer Patient: A Case Report

Rare Giant Ovarian Metastasis Arising from a Small Primary Lung Adenocarcinoma: a Case Report

An ALK-positive Lung Adenocarcinoma with Gastric and Skin Metastasis: a Case Report and Literature Review

Clinicopathologic Characteristics of ALK Rearrangements in Primary Lung Adenocarcinoma with Identified EGFR and KRAS Status.